Cargando…

Evaluation of Prevalence of Hepatitis E Clinical Markers among Donors in Estonia

Hepatitis E virus (HEV) is now considered the most common cause of acute hepatitis worldwide. There are no published data about the prevalence of antibodies to HEV and RNA in donor sera in Estonia, and this precludes planning measures for preventing HEV proliferation through blood transfusion servic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuznetsova, Tatiana, Moor, Diana, Khanirzayeva, Gulara, Geller, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612021/
https://www.ncbi.nlm.nih.gov/pubmed/37896895
http://dx.doi.org/10.3390/v15102118
_version_ 1785128608802537472
author Kuznetsova, Tatiana
Moor, Diana
Khanirzayeva, Gulara
Geller, Julia
author_facet Kuznetsova, Tatiana
Moor, Diana
Khanirzayeva, Gulara
Geller, Julia
author_sort Kuznetsova, Tatiana
collection PubMed
description Hepatitis E virus (HEV) is now considered the most common cause of acute hepatitis worldwide. There are no published data about the prevalence of antibodies to HEV and RNA in donor sera in Estonia, and this precludes planning measures for preventing HEV proliferation through blood transfusion services. Here, were report data from an analysis of 1002 sera on the prevalence of anti-HEV IgG and IgM and the viral RNA. The antibodies were found in 48 donor sera (4.8%); of these, 40 (4%) harbored anti-HEV IgG, 15 (1.5%) contained anti-HEV IgM, and 7 donors had anti-HEV antibodies of both classes simultaneously. HEV RNA was not detected in any blood serum. Statistical associations of infection risk factors (gender, age, travel in the last six months, contact with pigs and/or wild boars in the last six months, consumption of thermally unprocessed/raw pork or boar meat, raw/unfiltered tap water or water from natural sources, unpasteurized farm dairy products, and unwashed berries and/or vegetables) were assessed. None of the listed factors were found to be associated with a higher or lower risk of anti-HEV antibody presence. At the same time, an increasing share of anti-HEV IgG carriers with age was found. The absence of HEV RNA in the analyzed donor plasma samples proves that HEV acute infection prevalence in Estonia does not exceed the average level of European countries. There is no urgent necessity to enter a requirement for a total screening of blood plasma for HEV RNA prevalence in Estonia.
format Online
Article
Text
id pubmed-10612021
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106120212023-10-29 Evaluation of Prevalence of Hepatitis E Clinical Markers among Donors in Estonia Kuznetsova, Tatiana Moor, Diana Khanirzayeva, Gulara Geller, Julia Viruses Article Hepatitis E virus (HEV) is now considered the most common cause of acute hepatitis worldwide. There are no published data about the prevalence of antibodies to HEV and RNA in donor sera in Estonia, and this precludes planning measures for preventing HEV proliferation through blood transfusion services. Here, were report data from an analysis of 1002 sera on the prevalence of anti-HEV IgG and IgM and the viral RNA. The antibodies were found in 48 donor sera (4.8%); of these, 40 (4%) harbored anti-HEV IgG, 15 (1.5%) contained anti-HEV IgM, and 7 donors had anti-HEV antibodies of both classes simultaneously. HEV RNA was not detected in any blood serum. Statistical associations of infection risk factors (gender, age, travel in the last six months, contact with pigs and/or wild boars in the last six months, consumption of thermally unprocessed/raw pork or boar meat, raw/unfiltered tap water or water from natural sources, unpasteurized farm dairy products, and unwashed berries and/or vegetables) were assessed. None of the listed factors were found to be associated with a higher or lower risk of anti-HEV antibody presence. At the same time, an increasing share of anti-HEV IgG carriers with age was found. The absence of HEV RNA in the analyzed donor plasma samples proves that HEV acute infection prevalence in Estonia does not exceed the average level of European countries. There is no urgent necessity to enter a requirement for a total screening of blood plasma for HEV RNA prevalence in Estonia. MDPI 2023-10-19 /pmc/articles/PMC10612021/ /pubmed/37896895 http://dx.doi.org/10.3390/v15102118 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kuznetsova, Tatiana
Moor, Diana
Khanirzayeva, Gulara
Geller, Julia
Evaluation of Prevalence of Hepatitis E Clinical Markers among Donors in Estonia
title Evaluation of Prevalence of Hepatitis E Clinical Markers among Donors in Estonia
title_full Evaluation of Prevalence of Hepatitis E Clinical Markers among Donors in Estonia
title_fullStr Evaluation of Prevalence of Hepatitis E Clinical Markers among Donors in Estonia
title_full_unstemmed Evaluation of Prevalence of Hepatitis E Clinical Markers among Donors in Estonia
title_short Evaluation of Prevalence of Hepatitis E Clinical Markers among Donors in Estonia
title_sort evaluation of prevalence of hepatitis e clinical markers among donors in estonia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612021/
https://www.ncbi.nlm.nih.gov/pubmed/37896895
http://dx.doi.org/10.3390/v15102118
work_keys_str_mv AT kuznetsovatatiana evaluationofprevalenceofhepatitiseclinicalmarkersamongdonorsinestonia
AT moordiana evaluationofprevalenceofhepatitiseclinicalmarkersamongdonorsinestonia
AT khanirzayevagulara evaluationofprevalenceofhepatitiseclinicalmarkersamongdonorsinestonia
AT gellerjulia evaluationofprevalenceofhepatitiseclinicalmarkersamongdonorsinestonia